What is the recommended treatment for a penile infection caused by Streptococcus agalactiae (Group B Strep)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment for Penile Infection Caused by Streptococcus agalactiae (Group B Strep)

For penile infections caused by Group B Streptococcus (GBS), penicillin is the first-line treatment, with clindamycin 300 mg four times daily for 10 days recommended for non-pharyngeal infections or when penicillin treatment fails. 1

First-Line Treatment Options

For non-pregnant adults with GBS penile infections, the recommended treatment regimens include:

  • Penicillin-based options:

    • Oral penicillin V: 500 mg four times daily for 10 days 1
    • Amoxicillin: 500 mg three times daily for 10 days 1, 2
  • For penicillin-allergic patients:

    • Clindamycin: 300 mg four times daily for 10 days 1, 2
    • Azithromycin: 500 mg once daily for 5 days 1

Treatment Considerations for Non-Pharyngeal Infections

Since penile infections are non-pharyngeal, it's important to note that:

  • Penicillin treatment alone may not be sufficient for non-pharyngeal GBS infections 1
  • Clindamycin is particularly effective for non-pharyngeal carriage sites 1
  • For persistent or difficult-to-treat cases, combination therapy may be necessary 1

Monitoring and Follow-up

After treatment:

  • Clearance cultures should be taken 24 hours after completing treatment
  • Additional follow-up cultures at 1,3,6, and 12 weeks are recommended to ensure complete eradication 1

Management of Treatment Failure

If initial treatment fails:

  1. Consider clindamycin 300 mg four times daily for 10 days if penicillin was used initially 1
  2. For persistent infections, consider combination therapy options:
    • Penicillin plus rifampicin 1
    • Clindamycin with rifampicin 1

Special Considerations

  • Partner evaluation: Consider screening sexual partners, as GBS can be transmitted between partners 3
  • Recurrent infections: May require more aggressive treatment approaches and investigation of colonization in sexual partners 3
  • Risk factors: Patients with urinary tract abnormalities or compromised immune systems may require more aggressive treatment 2

Antibiotic Resistance Concerns

Be aware of increasing resistance patterns:

  • Penicillin resistance up to 18.3%
  • Clindamycin resistance rates of 14-26.6% 2

When selecting antibiotics, consider local resistance patterns and perform susceptibility testing when possible, especially for recurrent or persistent infections.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Group B Streptococcus Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Balanitis caused by group B streptococcus.

The Journal of urology, 1986

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.